Results of a haematological examination, liver function test, urine analysis and stool occult blood test were all within normal ranges.
Follow-up included physical examination, liver function testing, chest radiographs to check for pulmonary metastases, and ultrasonography, computed tomography, or magnetic resonance imaging to check for intrahepatic recurrence.
The prior RT work-up consisted of a complete medical history and examinations, including physical examination, AFP level, liver function test, renal function test, HBsAg, HBsAb, HBeAg, HBeAb, and HBV DNA quantification, abdominal ultrasonography, and CT evaluation of chest and abdomen for primary tumor and exclusion of distant organ metastasis.
Before radiotherapy (RT), all patients underwent imaging examinations and some baseline examinations, including CBC, liver function test, renal function test, α-fetoprotein level, hepatitis B (HB) surface antigen, HB surface Ab, HB e antigen, HB e Ab, and serum HBV DNA quantification.
Initial assessment included a complete history, clinical examination, serum biochemistry, liver function test, whole blood count and computed tomography scan (CT scan) and/or magnetic resonance imaging (MRI) of the tumor.
Only the sputum smear test was free, and I paid for X-ray examination, blood test and liver function test.
The follow-up program included serum AFP assay, liver function test, abdominal ultrasonography, and chest X-ray examination.
For the safety assessment, a liver function test, blood cell count test and physical examination will be performed at Visits 1, 2 and 5.
Patients received exact staging, including physical examination, complete blood count, urinalysis, liver function test, serum squamous cell carcinoma antigen (SCC Ag), chest X-ray, intravenous pyelography, and sigmoidoscopy.
Evaluations at each visit included complete blood count, liver function test, carcinoembryonic antigen (CEA) and cancer antigen 19 9 (CA19-9) measurements, and physical examination.
